How Astrea Bioseparations is expanding its expertise into the advanced medicines space.

Sending out instrumentation to trade shows or customer locations for demonstration purposes is expensive and not risk free. Enter 3D virtual worlds.

We interview Freya Biosciences' Colleen Acosta about the need for more therapies to address healthcare issues specific to women.

Acknowledging the monumental successes of the measles vaccine developer and “true giant” of science, medicine, and public health

Biopharma tech continues to advance so why is downstream processing such a headache?

Angelini Pharma launches crowdsourcing project to tackle drug-resistant epilepsy

Why the FDA must delete its statement that people are not horses (or cows), referring to ivermectin use

Testing directly on a diseased human cell is more efficient and more accurate, but ambition is lacking

We ask an expert from Elsevier about the future of digital tech in drug discovery.

The blood–brain barrier is a problem for most Alzheimer’s disease therapeutics, but ultrasound can help.